Skip to main content

Reporter

DNA: From modification to mutation

Jun. 8, 2012—Understanding how an environmental hazard damages DNA may shed light on processes of tumor formation.

Read more


Long live the therapeutic stem cells

May. 17, 2012—Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.

Read more


New clue to ADHD

May. 15, 2012—A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.

Read more


Intestinal artillery launches anti-bacterial attack

May. 14, 2012—The epithelial cells that line the intestines have a newly discovered mechanism for protecting us against microbes: they fire anti-bacterial "bullets" into the gut.

Read more


Perfect timing for sensory processing

May. 11, 2012—Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.

Read more


Vision study changes how we see the brain

May. 10, 2012—Vanderbilt researchers have discovered that the pulvinar, a mysterious structure buried in the center of our brains, determines how we see the world — and whether we see at all.

Read more


Probing epilepsy’s molecular sparks

May. 10, 2012—Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.

Read more


Early stomach troubles augur anxiety

May. 2, 2012—Children with stomach troubles grow up to be anxious adolescents and young adults, according to a recent study.

Read more


Better blood pressure-reducing drugs?

Apr. 30, 2012—A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.

Read more


Dengue antibodies give vaccine leads

Apr. 27, 2012—New information may help speed development of a vaccine or treatment for dengue fever.

Read more


Cost study shows timing crucial in appendectomies

Apr. 26, 2012—Removing a child’s ruptured appendix sooner rather than later significantly lowers hospital costs and charges, according to a recently published study.

Read more


New drug mutes more melanomas

Apr. 26, 2012—An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.

Read more


Recent Stories from VUMC News and Communications Publications

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

Vanderbilt Medicine

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

A diagnosis of cancer at any age is tragic, but during the adolescent and young adult years, it’s especially complicated.

Hope

A diagnosis of cancer at any age is tragic, but during the adolescent and young adult years, it’s especially complicated.

Karen Dyer Young cares for patients and members of the Dayani Center who have or are recovering from cancer or a stem cell transplant.

Momentum

Karen Dyer Young cares for patients and members of the Dayani Center who have or are recovering from cancer or a stem cell transplant.

more